CKD Chapter Five Part D prescription drug coverage

  • Slides: 27
Download presentation
CKD: Chapter Five Part D prescription drug coverage in patients with CKD United States

CKD: Chapter Five Part D prescription drug coverage in patients with CKD United States Renal Data System 2013 Annual Data Report USRDS 2013 ADR

Top 15 drug classes used by Part D enrollees with CKD, by percent of

Top 15 drug classes used by Part D enrollees with CKD, by percent of patients & drug class, 2011 Figure 5. 1 (Volume 1) CKD patients in the Medicare 5 percent sample. USRDS 2013 ADR

Sources of prescription drug coverage in Medicare enrollees, by population, 2011 Figure 5. 2

Sources of prescription drug coverage in Medicare enrollees, by population, 2011 Figure 5. 2 (Volume 1) Point prevalent Medicare enrollees alive on January 1, 2011. USRDS 2013 ADR

Sources of prescription drug coverage in Medicare enrollees, by age, 2011 Figure 5. 3

Sources of prescription drug coverage in Medicare enrollees, by age, 2011 Figure 5. 3 (Volume 1) Point prevalent Medicare enrollees alive on January 1, 2011. USRDS 2013 ADR

Sources of prescription drug coverage in Medicare enrollees, by race, 2011 Figure 5. 4

Sources of prescription drug coverage in Medicare enrollees, by race, 2011 Figure 5. 4 (Volume 1) Point prevalent Medicare enrollees alive on January 1, 2011. USRDS 2013 ADR

Distribution of low income subsidy (LIS) categories in Part D general Medicare, CKD, &

Distribution of low income subsidy (LIS) categories in Part D general Medicare, CKD, & ESRD patients, 2011 Figure 5. 5 (Volume 1) Point prevalent Medicare enrollees alive on January 1, 2011. USRDS 2013 ADR

Percent of Medicare Part D enrollees with/without low income subsidy (LIS), by age &

Percent of Medicare Part D enrollees with/without low income subsidy (LIS), by age & race, 2011 Table 5. a (Volume 1) Point prevalent Medicare enrollees alive on January 1, 2011. USRDS 2013 ADR

Medicare Part D benefit parameters for defined standard benefit, 2007 & 2011 Table 5.

Medicare Part D benefit parameters for defined standard benefit, 2007 & 2011 Table 5. b (Volume 1) http: //www. q 1 medicare. com/Part. D-The-2011 -Medicare-Part-D-Outlook. php. USRDS 2013 ADR

General Medicare, CKD, & ESRD patients enrolled in Part D (%) Table 5. c

General Medicare, CKD, & ESRD patients enrolled in Part D (%) Table 5. c (Volume 1) Point prevalent Medicare enrollees alive on January 1, excluding those in Medicare Advantage Part D plans. USRDS 2013 ADR

Part D non-LIS enrollees with specified monthly premium, 2006 & 2011 Figure 5. 6

Part D non-LIS enrollees with specified monthly premium, 2006 & 2011 Figure 5. 6 (Volume 1) Point prevalent Medicare enrollees alive on January 1, excluding those in Medicare Advantage Part D plans. USRDS 2013 ADR

Part D non-LIS enrollees with no deductible or with gap coverage, 2006 & 2011

Part D non-LIS enrollees with no deductible or with gap coverage, 2006 & 2011 Figure 5. 7 (Volume 1) Point prevalent Medicare enrollees alive on January 1, excluding those in Medicare Advantage Part D plans. USRDS 2013 ADR

Part D LIS enrollees with specified co-insurance/copayment, 2006 & 2011 Figure 5. 8 (Volume

Part D LIS enrollees with specified co-insurance/copayment, 2006 & 2011 Figure 5. 8 (Volume 1) Point prevalent Medicare enrollees alive on January 1, excluding those in Medicare Advantage Part D plans. USRDS 2013 ADR

Total estimated net Part D costs for enrollees Figure 5. 9 (Volume 1) General

Total estimated net Part D costs for enrollees Figure 5. 9 (Volume 1) General Medicare totals include Part D claims for all patients in the Medicare 5 percent sample enrolled in Part D. CKD total includes Medicare CKD patients, as determined from claims. ESRD totals include all Part D claims for Medicare ESRD patients enrolled in Part D. USRDS 2013 ADR

Per person per year Medicare & out-of-pocket Part D costs for enrollees, 2011 Figure

Per person per year Medicare & out-of-pocket Part D costs for enrollees, 2011 Figure 5. 10 (Volume 1) General Medicare totals include Part D claims for all patients in the Medicare 5 percent sample enrolled in Part D. CKD totals includes Medicare CKD patients, as determined from claims. ESRD totals include all Part D claims for Medicare ESRD patients enrolled in Part D. Costs are person per year for calendar year 2011. Medicare total is the sum of Medicare net payment plus LIS amount. USRDS 2013 ADR

Per person per year Part D costs for enrollees, by low income subsidy (LIS)

Per person per year Part D costs for enrollees, by low income subsidy (LIS) status, 2011 Figure 5. 11 (Volume 1) General Medicare totals include Part D claims for all patients in the Medicare 5 percent sample enrolled in Part D. CKD totals includes Medicare CKD patients, as determined from claims. ESRD totals include all Part D claims for Medicare ESRD patients enrolled in Part D. Costs are PPPY for calendar year 2011. Low income subsidy (LIS) status is determined from the Part D enrollment. A person is classified as LIS if they are eligible for the LIS for at least one month during 2011. USRDS 2013 ADR

Total person per year Part D costs ($) for enrollees, by LIS status, 2011

Total person per year Part D costs ($) for enrollees, by LIS status, 2011 Table 5. d (Volume 1) All Medicare patients enrolled in Part D, 2011. CKD determined from claims. ESRD: period prevalent ESRD patients, 2011. Costs are person per year for calendar year 2011. Medicare PPPY is the sum of Medicare payment amount & low income subsidy amount. Low income subsidy (LIS) status is determined from the Part D enrollment. A person is classified as LIS if they are eligible for the low income subsidy for at least one month during 2011. USRDS 2013 ADR

Part D enrollees not receiving the low income subsidy (LIS) who reach coverage phase,

Part D enrollees not receiving the low income subsidy (LIS) who reach coverage phase, 2011 Figure 5. 12 (Volume 1) Point-prevalent Medicare enrollees alive on January 1, excluding those in employer-sponsored & national PACE Part D plans. USRDS 2013 ADR

Twelve-month probability (%) of reaching the coverage gap in Part D enrollees not receiving

Twelve-month probability (%) of reaching the coverage gap in Part D enrollees not receiving the low income subsidy (LIS), 2011 Table 5. e (Volume 1) Point prevalent Medicare enrollees alive on January 1, excluding those in employer-sponsored & national PACE Part D plans. USRDS 2013 ADR

Medicare Part D CKD patients with at least one claim for an ACEI/ARB/renin inhibitor

Medicare Part D CKD patients with at least one claim for an ACEI/ARB/renin inhibitor in the 12 months following the disease defining entry period, by CKD diagnosis code, 2011 Figure 5. 13 (Volume 1) Point prevalent Medicare CKD patients age 65 & older. USRDS 2013 ADR

Medicare Part D CKD patients with at least one claim for a beta blocker

Medicare Part D CKD patients with at least one claim for a beta blocker in the 12 months following the disease defining entry period, by CKD diagnosis code, 2011 Figure 5. 14 (Volume 1) Point prevalent Medicare CKD patients age 65 & older. USRDS 2013 ADR

Medicare Part D CKD patients with at least one claim for a DHP calcium

Medicare Part D CKD patients with at least one claim for a DHP calcium channel blocker in the 12 months following the disease -defining entry period, by CKD diagnosis code, 2011 Figure 5. 15 (Volume 1) Point prevalent Medicare CKD patients age 65 & older. USRDS 2013 ADR

CKD patients with at least one claim for a diuretic in the 12 months

CKD patients with at least one claim for a diuretic in the 12 months following the disease-defining entry period, by CKD diagnosis code, 2011 Figure 5. 16 (Volume 1) Point prevalent Medicare CKD patients age 65 & older. USRDS 2013 ADR

ACEI/ARB/renin inhibitor use in Part D enrollees in the transition to ESRD, 2011 Figure

ACEI/ARB/renin inhibitor use in Part D enrollees in the transition to ESRD, 2011 Figure 5. 17 (Volume 1) Point prevalent Medicare CKD patients age 67 & older. USRDS 2013 ADR

Beta blocker use in Part D enrollees in the transition to ESRD, 2011 Figure

Beta blocker use in Part D enrollees in the transition to ESRD, 2011 Figure 5. 18 (Volume 1) Point prevalent Medicare CKD patients age 67 & older. USRDS 2013 ADR

DHP calcium channel blocker use in Part D enrollees in the transition to ESRD,

DHP calcium channel blocker use in Part D enrollees in the transition to ESRD, 2011 Figure 5. 19 (Volume 1) Point prevalent Medicare CKD patients age 67 & older. USRDS 2013 ADR

Diuretic use in Part D enrollees during the transition to ESRD, by CKD diagnosis

Diuretic use in Part D enrollees during the transition to ESRD, by CKD diagnosis code, 2011 Figure 5. 20 (Volume 1) Point prevalent Medicare CKD patients age 67 & older. USRDS 2013 ADR

Top 15 drug classes in by Part D enrollees with CKD, by % of

Top 15 drug classes in by Part D enrollees with CKD, by % of patients & drug class, 2011 Table 5. f (Volume One) CKD patients in the Medicare 5 percent sample. USRDS 2013 ADR

CKD Chapter Five Prescription drug coverage Medicare PartCKD Chapter Five Prescription drug coverage Medicare Part
CKD CHORONIC KIDNEY DISEASE What is CKD CKDCKD CHORONIC KIDNEY DISEASE What is CKD CKD
CKD CKD 2013 1 CKD 22 30 25CKD CKD 2013 1 CKD 22 30 25
Prescription Drug drug that requires a prescription becausePrescription Drug drug that requires a prescription because
ESRD Chapter Six Prescription drug coverage Medicare PartESRD Chapter Six Prescription drug coverage Medicare Part
Principles of Prescription Order Writing Prescription The prescriptionPrinciples of Prescription Order Writing Prescription The prescription
Prescription writing Prescription Medical Prescription is the prescribersPrescription writing Prescription Medical Prescription is the prescribers
Prescription Drugs Mr Prall Prescription Drugs introduction PrescriptionPrescription Drugs Mr Prall Prescription Drugs introduction Prescription
The prescription Prescription Prescription is an order forThe prescription Prescription Prescription is an order for
LA PRESCRIPTION MEDICALE Prescription mdicale Introduction Prescription mdicaleLA PRESCRIPTION MEDICALE Prescription mdicale Introduction Prescription mdicale
Prescription writing Prescription Medical Prescription is the prescribersPrescription writing Prescription Medical Prescription is the prescribers
LA PRESCRIPTION MEDICALE Prescription mdicale Introduction Prescription mdicaleLA PRESCRIPTION MEDICALE Prescription mdicale Introduction Prescription mdicale
LA PRESCRIPTION MEDICALE Prescription mdicale Introduction Prescription mdicaleLA PRESCRIPTION MEDICALE Prescription mdicale Introduction Prescription mdicale
CKD Chapter One CKD in the general populationCKD Chapter One CKD in the general population
CKD Chapter Four Cardiovascular disease patients with CKDCKD Chapter Four Cardiovascular disease patients with CKD
Why this CME on CKD CKD is aWhy this CME on CKD CKD is a
Last updated 23042019 CKD Stage 1 90 CKDLast updated 23042019 CKD Stage 1 90 CKD
Official Prescription Program 2 Prescription Drug Reform ActOfficial Prescription Program 2 Prescription Drug Reform Act
Official Prescription Program 2 Prescription Drug Reform ActOfficial Prescription Program 2 Prescription Drug Reform Act
Data Coverage and Code Coverage Data Coverage DataData Coverage and Code Coverage Data Coverage Data
WhiteBox Testing Statement coverage Branch coverage Path coverageWhiteBox Testing Statement coverage Branch coverage Path coverage
Medicare D Prescription Drug Coverage Module 2 JayashriMedicare D Prescription Drug Coverage Module 2 Jayashri
Medicare Prescription Drug Coverage SHIBA and WA VersionMedicare Prescription Drug Coverage SHIBA and WA Version
JAMA Ophthalmology Journal Club Slides Prescription Drug CoverageJAMA Ophthalmology Journal Club Slides Prescription Drug Coverage